Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodcock, J.
Right arrow Articles by Kennedy, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodcock, J.
Right arrow Articles by Kennedy, S. K.

Stroke, Vol 13, 785-787, Copyright © 1982 by American Heart Association


ARTICLES

High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome

J Woodcock, AH Ropper and SK Kennedy

High dose barbiturates were used to treat intracranial hypertension in 15 patients with nontraumatic brain lesions; (3 hypertensive hemorrhage, 4 subarachnoid hemorrhage, 5 infarction, 2 global anoxia- ischemia and 2 encephalitis). All had persistently raised intracranial pressure (ICP) while being treated with aggressive conventional therapy. The addition of barbiturates caused an initial lowering of ICP in 11 patients, but only 5 of these had sustained ICP reductions. Survival of the 5 patients with persistently lowered ICP and death of the remaining 10 may indicate an improvement in outcome attributable to the addition of high dose barbiturates to conventional therapy in non- traumatic brain swelling. Because of the resources required for their prolonged use, randomized studied in patients with intracranial hypertension are required to determine the effect of barbiturates on outcome.


This article has been cited by other articles:


Home page
StrokeHome page
J. Bardutzky and S. Schwab
Antiedema Therapy in Ischemic Stroke
Stroke, November 1, 2007; 38(11): 3084 - 3094.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al.
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Stroke, April 1, 2003; 34(4): 1056 - 1083.
[Full Text] [PDF]


Home page
NEJMHome page
A. I. Qureshi, S. Tuhrim, J. P. Broderick, H. H. Batjer, H. Hondo, and D. F. Hanley
Spontaneous Intracerebral Hemorrhage
N. Engl. J. Med., May 10, 2001; 344(19): 1450 - 1460.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
L. R. Wechsler
Analytic Reviews : Potential New Therapies for Acute Ischemic Stroke
J Intensive Care Med, September 1, 1988; 3(5): 258 - 264.
[Abstract] [PDF]